Forte Biosciences
FBRX
FBRX
33 hedge funds and large institutions have $127M invested in Forte Biosciences in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+4
Holders Change %
+13.79%
% of All Funds
0.44%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
8
Increased
15
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$13.9M |
| 2 |
FAM
Fred Alger Management
New York
|
+$9.15M |
| 3 |
O
OrbiMed
New York
|
+$7.81M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$6.4M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$6.22M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $1.95K | – | – | – |
|
27
Group One Trading
Chicago,
Illinois
| $1.35K | – | – | – |
|
28
Bank of America
Charlotte,
North Carolina
| $711 | +$116 | +9 | +20% |
|
|
SS
29
SBI Securities
Tokyo,
Japan
| $155 | – | – | – |
|
30
BNP Paribas Financial Markets
Paris,
France
| $103 | – | – | – |
|
|
RFG
31
REAP Financial Group
Austin,
Texas
| $39 | – | – | – |
|
32
Wells Fargo
San Francisco,
California
| $26 | +$26 | +2 | New |
|
33
UBS Group
Zurich,
Switzerland
| $13 | -$6.84K | -526 | -100% |
|
|
FCM
34
Farallon Capital Management
San Francisco,
California
| – | -$547K | -70,429 | Closed |
|
|
ACP
35
Acuta Capital Partners
Redwood City,
California
| – | -$143K | -18,469 | Closed |
|
|
TRCT
36
Tower Research Capital (TRC)
New York
| – | -$13.9K | -1,792 | Closed |
|
37
JPMorgan Chase & Co
New York
| – | -$23 | -3 | Closed |
|